Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/47481
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | “Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK”: How important is quality of life? |
Author: | Bansback, N. Ward, S. Karnon, J. |
Citation: | European Journal of Health Economics, 2004; 5(2):188-189 |
Publisher: | Springer |
Issue Date: | 2004 |
ISSN: | 1618-7598 1618-7601 |
Statement of Responsibility: | Nick Bansback, Sue Ward and Jon Karnon |
Keywords: | Gemcitabine Economic evaluation Expected value of information |
Description: | The original publication can be found at www.springerlink.com |
Provenance: | Published online: 27 February 2004 |
DOI: | 10.1007/s10198-004-0226-5 |
Published version: | http://springerlink.metapress.com/content/3m7uurmtclxf60n5/ |
Appears in Collections: | Aurora harvest Public Health publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.